JAGX

insider transactions

Jaguar Health, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Dec 11, 25

John Micek

Director

$0

7.4K sh

Own New
Grant·A
Dec 11, 25

John Micek

Director

$0

7.4K sh

Own +13919%
Grant·A
Dec 11, 25

Steven R. King

Chief of Sustainable Supply, …

$0

11.7K sh

Own New
Grant·A
Dec 11, 25

Steven R. King

Chief of Sustainable Supply, …

$0

11.7K sh

Own +8097%
Grant·A
Dec 11, 25

Jonathan S. Wolin

Chief of Staff, Chief Complia…

$0

11.7K sh

Own New
Grant·A
Dec 11, 25

Jonathan S. Wolin

Chief of Staff, Chief Complia…

$0

11.7K sh

Own +5929%
Grant·A
Dec 11, 25

Lisa A Conte KEY

Chief Exec. Officer & Preside…

$0

28.6K sh

Own New
Grant·A
Dec 11, 25

Lisa A Conte KEY

Chief Exec. Officer & Preside…

$0

28.6K sh

Own +4293%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Dec 11, 2025	John Micek	Director	Grant A	7.4K	New	—	$0
Dec 11, 2025	John Micek	Director	Grant A	7.4K	+13919%	—	$0
Dec 11, 2025	Steven R. King	Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary	Grant A	11.7K	New	—	$0
Dec 11, 2025	Steven R. King	Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary	Grant A	11.7K	+8097%	—	$0
Dec 11, 2025	Jonathan S. Wolin	Chief of Staff, Chief Compliance Officer & General Counsel	Grant A	11.7K	New	—	$0
Dec 11, 2025	Jonathan S. Wolin	Chief of Staff, Chief Compliance Officer & General Counsel	Grant A	11.7K	+5929%	—	$0
Dec 11, 2025	Lisa A Conte KEY	Chief Exec. Officer & President	Grant A	28.6K	New	—	$0
Dec 11, 2025	Lisa A Conte KEY	Chief Exec. Officer & President	Grant A	28.6K	+4293%	—	$0

About JAGX insider trading

This page tracks insider transactions for Jaguar Health, Inc. (JAGX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.